Renalytix AI plc IPO Advisory
Share this IPO Profile:
Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on Renalytix AI plc, and our comprehensive analysis, click "
Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Renalytix AI plc | RNLX - NASDAQ |
$14.22-$14.22 |
$13.50 |
$13.90 | 5.5 million ADSs | 7/17/2020 |
JP Morgan, Stifel |
Co-Manager(s): |
Health Care |
Filing(s): Filed 2020-06-24 Terms Added 2020-07-13
|
Renalytix AI plc Quote & Chart - Click for current quote -
RNLX
About Renalytix AI plc (adapted from Renalytix AI plc prospectus):
They are an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Their ordinary shares trade on AIM, a market operated by the London Stock Exchange, under the symbol “RENX.â€
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "RNLX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2025 IPO Boutique. All Rights Reserved